180 related articles for article (PubMed ID: 35174322)
1. Ageing contributes to phenotype transition in a mouse model of periodic paralysis.
Suetterlin KJ; Tan SV; Mannikko R; Phadke R; Orford M; Eaton S; Sayer AA; Grounds MD; Matthews E; Greensmith L; Hanna MG
JCSM Rapid Commun; 2021; 4(2):245-259. PubMed ID: 35174322
[TBL] [Abstract][Full Text] [Related]
2. A204E mutation in Na
Kokunai Y; Dalle C; Vicart S; Sternberg D; Pouliot V; Bendahhou S; Fournier E; Chahine M; Fontaine B; Nicole S
Sci Rep; 2018 Nov; 8(1):16681. PubMed ID: 30420713
[TBL] [Abstract][Full Text] [Related]
3. Atypical periodic paralysis and myalgia: A novel
Matthews E; Neuwirth C; Jaffer F; Scalco RS; Fialho D; Parton M; Raja Rayan D; Suetterlin K; Sud R; Spiegel R; Mein R; Houlden H; Schaefer A; Healy E; Palace J; Quinlivan R; Treves S; Holton JL; Jungbluth H; Hanna MG
Neurology; 2018 Jan; 90(5):e412-e418. PubMed ID: 29298851
[TBL] [Abstract][Full Text] [Related]
4. Defective slow inactivation of sodium channels contributes to familial periodic paralysis.
Hayward LJ; Sandoval GM; Cannon SC
Neurology; 1999 Apr; 52(7):1447-53. PubMed ID: 10227633
[TBL] [Abstract][Full Text] [Related]
5. The clinical and genetic heterogeneity analysis of five families with primary periodic paralysis.
Wang Q; Zhao Z; Shen H; Bing Q; Li N; Hu J
Channels (Austin); 2021 Dec; 15(1):20-30. PubMed ID: 33345742
[TBL] [Abstract][Full Text] [Related]
6. Recovery from acidosis is a robust trigger for loss of force in murine hypokalemic periodic paralysis.
Mi W; Wu F; Quinonez M; DiFranco M; Cannon SC
J Gen Physiol; 2019 Apr; 151(4):555-566. PubMed ID: 30733232
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of bumetanide in a CaV1.1-R528H mouse model of hypokalaemic periodic paralysis.
Wu F; Mi W; Cannon SC
Brain; 2013 Dec; 136(Pt 12):3766-74. PubMed ID: 24142145
[TBL] [Abstract][Full Text] [Related]
8. The primary periodic paralyses: diagnosis, pathogenesis and treatment.
Venance SL; Cannon SC; Fialho D; Fontaine B; Hanna MG; Ptacek LJ; Tristani-Firouzi M; Tawil R; Griggs RC;
Brain; 2006 Jan; 129(Pt 1):8-17. PubMed ID: 16195244
[TBL] [Abstract][Full Text] [Related]
9. Effect of phenytoin on skeletal muscle from quarter horses with hyperkalaemic periodic paralysis.
Beech J; Fletcher JE; Tripolitis L; Lindborg S; Dawso T
Res Vet Sci; 1995 May; 58(3):206-11. PubMed ID: 7659842
[TBL] [Abstract][Full Text] [Related]
10. The mechanism underlying transient weakness in myotonia congenita.
Myers JH; Denman K; DuPont C; Hawash AA; Novak KR; Koesters A; Grabner M; Dayal A; Voss AA; Rich MM
Elife; 2021 Apr; 10():. PubMed ID: 33904400
[TBL] [Abstract][Full Text] [Related]
11. Expression patterns of two potassium channel genes in skeletal muscle cells of patients with familial hypokalemic periodic paralysis.
Kim JB; Lee GM; Kim SJ; Yoon DH; Lee YH
Neurol India; 2011; 59(4):527-31. PubMed ID: 21891927
[TBL] [Abstract][Full Text] [Related]
12. The human skeletal muscle Na channel mutation R669H associated with hypokalemic periodic paralysis enhances slow inactivation.
Struyk AF; Scoggan KA; Bulman DE; Cannon SC
J Neurosci; 2000 Dec; 20(23):8610-7. PubMed ID: 11102465
[TBL] [Abstract][Full Text] [Related]
13. A calcium channel mutant mouse model of hypokalemic periodic paralysis.
Wu F; Mi W; Hernández-Ochoa EO; Burns DK; Fu Y; Gray HF; Struyk AF; Schneider MF; Cannon SC
J Clin Invest; 2012 Dec; 122(12):4580-91. PubMed ID: 23187123
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and molecular genetic analysis of a family with normokalemic periodic paralysis].
Wei CJ; Wang D; Wang S; Jiao H; Hong DJ; Pu LH; Xiong H
Zhonghua Er Ke Za Zhi; 2013 Jan; 51(1):47-51. PubMed ID: 23527931
[TBL] [Abstract][Full Text] [Related]
15. Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A.
Sternberg D; Maisonobe T; Jurkat-Rott K; Nicole S; Launay E; Chauveau D; Tabti N; Lehmann-Horn F; Hainque B; Fontaine B
Brain; 2001 Jun; 124(Pt 6):1091-9. PubMed ID: 11353725
[TBL] [Abstract][Full Text] [Related]
16. Muscle weakness in Ryr1I4895T/WT knock-in mice as a result of reduced ryanodine receptor Ca2+ ion permeation and release from the sarcoplasmic reticulum.
Loy RE; Orynbayev M; Xu L; Andronache Z; Apostol S; Zvaritch E; MacLennan DH; Meissner G; Melzer W; Dirksen RT
J Gen Physiol; 2011 Jan; 137(1):43-57. PubMed ID: 21149547
[TBL] [Abstract][Full Text] [Related]
17. Slow inactivation differs among mutant Na channels associated with myotonia and periodic paralysis.
Hayward LJ; Brown RH; Cannon SC
Biophys J; 1997 Mar; 72(3):1204-19. PubMed ID: 9138567
[TBL] [Abstract][Full Text] [Related]
18. An atypical phenotype of hypokalemic periodic paralysis caused by a mutation in the sodium channel gene SCN4A.
Park YH; Kim JB
Korean J Pediatr; 2010 Oct; 53(10):909-12. PubMed ID: 21189962
[TBL] [Abstract][Full Text] [Related]
19. A sodium channel knockin mutant (NaV1.4-R669H) mouse model of hypokalemic periodic paralysis.
Wu F; Mi W; Burns DK; Fu Y; Gray HF; Struyk AF; Cannon SC
J Clin Invest; 2011 Oct; 121(10):4082-94. PubMed ID: 21881211
[TBL] [Abstract][Full Text] [Related]
20. Barium-treated mammalian skeletal muscle: similarities to hypokalaemic periodic paralysis.
Gallant EM
J Physiol; 1983 Feb; 335():577-90. PubMed ID: 6308221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
